DRUG · Unmapped registry intervention
Gallium maltolate
Find medicine records ·
Find other trials using this name
Clinical trial
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
NCT00050687
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSafety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostatic Neoplasmsunresolved
Multiple Myelomaunresolved
Bladder Neoplasmsunresolved
Lymphomaverified · MONDO: lymphoma
Interventions
Sponsors & collaborators
Titan Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00050687 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.